OCT 27, 2016 5:53 AM PDT

Scripps Florida Scientists Illuminate Key Molecular Player in Both Morphine Addiction and Rare Disease


JUPITER, FL – October 26, 2016 – In a remarkable “two for one” discovery, scientists from the Florida campus of The Scripps Research Institute (TSRI) have illuminated a key molecular player in the addictive effects of morphine in animal models.

Interestingly, the protein—known as neurofibromin 1 (NF1)—is also known to be disrupted in an inherited disorder called neurofibromatosis type 1 (also called von Recklinghausen's disease), in which patients suffer from the growth of benign tumors beneath the skin, chronic pain, mild learning disabilities and an elevated risk of developing cancers.

“We were searching for proteins that influence the long-term effects of opioids,” said TSRI Professor Kirill Martemyanov. “In the short-term, opioids kill pain, but we were curious about mechanisms that lead to long-term adaptations that ultimately result in addiction. We screened for proteins that might possibly be involved in this process and what emerged was NF1.”

The study, recently published online ahead of print in the journal Current Biology, describes how NF1 influences opioid response through its impact on a signaling protein known as Ras in a part of the brain called the striatum, which is involved in decision making and reward.

When the researchers deleted NF1 in striatal neurons of animal models, opioids failed to engage Ras and its downstream signaling reactions, dramatically diminishing the addictive effects of morphine.

“One of the peculiar symptoms of neurofibromatosis type 1 is that patients often suffer from chronic, unexplained pain,” said Martemyanov. “Given that the endogenous opioid system is involved in controlling pain sensitivity and the role of NF1 protein in mediating signaling of opioid receptors, it makes sense that if the mechanism is broken pain, might become an issue.”

He also noted the results suggest potential therapies for both conditions: “If you came up with a strategy to inhibit NF1 activity, perhaps the opioids won’t be as addictive; but for those suffering from the neurofibromatosis, bypassing NF1 to activate Ras by receptors may be interesting to explore.”

The first author of the study, “NF1 Is a Direct G Protein Effector Essential for Opioid Signaling to Ras in the Striatum,” is Keqiang Xie. Other authors include Maria T. Dao, Brian S. Muntean, Laurie P. Sutton, Cesare Orlandi, Chien-Cheng Shih, Baoji Xu and Roy G. Smith of TSRI; Lesley A. Colgan and Ryohei Yasuda the Max Planck Florida Institute for Neuroscience; and Sanford L. Boye, Shannon E. Boye and Yuqing Li of the University of Florida.

The study was supported by the National Institutes of Health (grants DA036082, MH080047, MH101954, NS82244, NS073930 and EY024280); and the Department of Defense (CDMRP grant W81XWH-14-1-0074).

This article was originally published on Scripps.edu.
About the Author
  • The Scripps Research Institute (TSRI) is one of the world's largest independent, not-for-profit organizations focusing on research in the biomedical sciences. TSRI is internationally recognized for its contributions to science and health, including its role in laying the foundation for new treatments for cancer, rheumatoid arthritis, hemophilia, and other diseases. An institution that evolved from the Scripps Metabolic Clinic founded by philanthropist Ellen Browning Scripps in 1924, the institute now employs about 2,700 people on its campuses in La Jolla, CA, and Jupiter, FL, where its renowned scientists-including two Nobel laureates-work toward their next discoveries. The institute's graduate program, which awards PhD degrees in biology and chemistry, ranks among the top ten of its kind in the nation. For more information, see www.scripps.edu.
You May Also Like
AUG 24, 2021
Health & Medicine
Cannabis Use and Cardiovascular Disease- A Lesson in Causality
AUG 24, 2021
Cannabis Use and Cardiovascular Disease- A Lesson in Causality
As the march toward legalization of Marijuana use continues amidst ongoing debate, more attention has been paid to the i ...
SEP 01, 2021
Technology
Keep 6 Inches Away: Smartphones and Watches Can Interfere With Implanted Medical Devices
SEP 01, 2021
Keep 6 Inches Away: Smartphones and Watches Can Interfere With Implanted Medical Devices
Recent guidance by the U.S Food and Drug Administration (FDA) recommended that people with implanted medical devices sho ...
AUG 30, 2021
Cell & Molecular Biology
A CRISPR-Cas to Target RNA Viruses
AUG 30, 2021
A CRISPR-Cas to Target RNA Viruses
The microbes of the world are constantly competing with one another. There are viruses that can infect bacteria, called ...
SEP 02, 2021
Immunology
Will an Extra COVID Vaccine Shot Benefit People With Autoimmune Conditions?
SEP 02, 2021
Will an Extra COVID Vaccine Shot Benefit People With Autoimmune Conditions?
The global rollout of COVID-19 vaccines has helped save countless lives during the pandemic. Studies have shown that vac ...
SEP 10, 2021
Health & Medicine
Intervention for Endocarditis- What Kind of Valve is Best?
SEP 10, 2021
Intervention for Endocarditis- What Kind of Valve is Best?
  Infective endocarditis is caused when a bacterium such as staphylococcus enters the bloodstream and infects heart ...
SEP 14, 2021
Health & Medicine
A lower sodium diet decreases the chance of stroke and other heart disease
SEP 14, 2021
A lower sodium diet decreases the chance of stroke and other heart disease
A new study found that using a low salt alternative lowered the risk of stroke and other heart disease
Loading Comments...